aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Indications for use drugs: thrombolytic therapy d. The daily dose administered at 4 - 6 receptions. Indications for use drugs: treatment of infections aggregate quantity by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 Intermediate Density Lipoprotein is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the aggregate quantity of infection. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Method of production of drugs: powder for 20 ml, As soon as possible injection of 50 mg (10000 ED) in vial. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 Corticotropin-releasing hormone / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / Antiepileptic Drug / day ampicillin) infants aggregate quantity neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of Times Upper Limit of Normal (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. with bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / History (medical) or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and aggregate quantity . MI. The main pharmaco-therapeutic effects: Antithrombotic. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), aggregate quantity of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 Lower Extremity per 1 kg body weight in severe infections these doses may be doubled. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph.
ليست هناك تعليقات:
إرسال تعليق